Purchase Order 75N91022P00428
Award Date 8/1/22
Potential Completion Date 7/31/23
Potential Value $120K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance services on a government-owned Illumina NovaSeq 6000 sequencing instrument. The $134,247.36 contract provides annual preventive maintenance, emergency repair, software/firmware updates, replacement parts, and technical support for the sequencing system located at the NCI's Laboratory of Pathology in Bethesda,...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $184,285.77 contract is for maintenance services on the government-owned Illumina NovaSeq 6000 genetic sequencing equipment, to ensure it operates safely and with minimal downtime. The original solicitation called for the contractor...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance and repair services of Illumina's NovaSeq 6000 sequencing equipment. The contract has a ceiling value of $43,380.00 and a period of performance ending on October 12, 2025. The contract was awarded on a sole-source basis, as Illumina is the original equipment manufacturer of the NovaSeq 6000 sequencer....
- The National Cancer Institute (NCI), a component of the National Institutes of Health under the Department of Health and Human Services, awarded a $67,824 firm fixed-price purchase order to Illumina, Inc. for preventive maintenance, emergency service, support, and coverage of a government-owned Illumina NovaSeq 6000 sequencing system located at the NCI's Center for Cancer Research facility in San Diego, California. The contract, awarded on May 1, 2021, with a completion date of April 30, 2022,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,646 purchase order to Illumina, Inc. for service agreement on a NovaSeq 6000 sequencer. The firm fixed price contract runs from December 1, 2023 through January 17, 2024 and will be performed in Rockville, Maryland. This purchase order provides sequencing services utilizing Illumina's NovaSeq 6000 platform to support the National Cancer Institute's cancer research efforts. No major...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Illumina, Inc. for preventative maintenance service on a government-owned Illumina NextSeq 550 DNA sequencing instrument. The contract has a potential value of $189,482.72 and a completion date of March 28, 2024. It does not have any set-aside designation. As a manufacturer of genomic sequencing instruments and reagents, Illumina has...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract provides for preventive and emergency maintenance of government-owned Illumina instrumentation, including MiSeq, cBOT, Freedom EVO, and NextSeq 500 systems, utilized for genome analysis in support of NCI's cancer research....
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and consumables. The contract is for Illumina's NextSeq 500 Sequencing System Production Care comprehensive support plan, with a potential value of $145,851.23 and a completion date of January 31, 2023. Illumina has previously received awards from federal agencies like the...
- The National Cancer Institute awarded a $735,959 firm fixed-price purchase order to Illumina, Inc. on March 18, 2024, for preventive maintenance and emergency repair services supporting a government-owned Illumina NovaSeq 6000 sequencing system at the National Institutes of Health Clinical Center in Bethesda, Maryland. The contract encompasses a one-year base period (March 2024 through March 2025) and includes four one-year option periods, extending through March 2029. Services include annual...